Old Mission Capital’s KALA BIO KALA Stock Holding History

Old Mission Capital’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6	Closed	-$113K	–	609
2020 Q3	$113K	Buy	+6	New	+$138K	0.01%	411

Other funds holding KALA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Old Mission Capital's KALA Position: Q4 2020 in Review

Old Mission Capital sold out of KALA BIO (KALA) in Q4 2020, closing a stake of 6 shares — an estimated $113K sold.

Old Mission Capital first reported a position in KALA in Q3 2020 and held it in 1 quarter. The position peaked at $113K in Q3 2020. 112 funds tracked by Wall St. Rank hold KALA as of Q4 2020.

Old Mission Capital reported no remaining KALA BIO position as of Q4 2020 after selling out during the quarter.
Old Mission Capital sold 6 KALA BIO shares in Q4 2020, an estimated $113K.
Old Mission Capital first reported a position in KALA BIO in Q3 2020 and held it in 1 quarter.
Old Mission Capital's KALA BIO position peaked at $113K in Q3 2020.
112 funds tracked by Wall St. Rank held KALA BIO as of Q4 2020.

Based on Old Mission Capital's 13F filing for Q4 2020, filed 17 Feb 2021.